Literature DB >> 24003277

Photodynamic therapy with ablative carbon dioxide fractional laser for treating Bowen disease.

Sue Kyung Kim1, Ji-Youn Park, Hyo Sang Song, You-Sun Kim, You Chan Kim.   

Abstract

BACKGROUND: Topical photodynamic therapy (PDT) has been increasingly used to treat malignant skin tumors including the Bowen disease. However, patients could be displeased with the long incubation time required for conventional PDT.
OBJECTIVE: We evaluated the efficacy and safety of PDT with a short incubation time of ablative CO2 fractional laser pretreatment for treating Bowen disease.
METHODS: Ten patients were included. Just before applying the topical photosensitizer, all lesions were treated with ablative CO2 fractional laser, following the application of methyl aminolevulinate and irradiation with red light (Aktilite CL 128). Histological confirmation, rebiopsy, and clinical assessments were performed. Adverse events were also recorded.
RESULTS: Five of the ten (50%) lesions showed a complete response (CR) within three PDT sessions. After four treatment sessions, all lesions except one penile shaft lesion (90%) achieved clinical and histological CR or clinical CR only. The average number of treatments to CR was 3.70±1.70. The treatments showed favorable cosmetic outcomes and no serious adverse events.
CONCLUSION: The results suggest that pretreatment with an ablative fractional CO2 laser before PDT has similar treatment efficacy and requires a shorter photosensitizer incubation time compared with the conventional PDT method.

Entities:  

Keywords:  Ablative carbon dioxide fractional laser; Bowen disease; Photodynamic therapy; Pretreatment

Year:  2013        PMID: 24003277      PMCID: PMC3756199          DOI: 10.5021/ad.2013.25.3.335

Source DB:  PubMed          Journal:  Ann Dermatol        ISSN: 1013-9087            Impact factor:   1.444


  20 in total

1.  Guidelines for management of Bowen's disease. British Association of Dermatologists.

Authors:  N H Cox; D J Eedy; C A Morton
Journal:  Br J Dermatol       Date:  1999-10       Impact factor: 9.302

Review 2.  Bowen's disease, solar keratoses and superficial basal cell carcinomas treated by photodynamic therapy using a large-field incoherent light source.

Authors:  S Varma; H Wilson; H A Kurwa; B Gambles; C Charman; A D Pearse; D Taylor; A V Anstey
Journal:  Br J Dermatol       Date:  2001-03       Impact factor: 9.302

Review 3.  Methyl aminolaevulinate-photodynamic therapy: a review of clinical trials in the treatment of actinic keratoses and nonmelanoma skin cancer.

Authors:  P Lehmann
Journal:  Br J Dermatol       Date:  2007-04-05       Impact factor: 9.302

Review 4.  Guidelines for topical photodynamic therapy: update.

Authors:  C A Morton; K E McKenna; L E Rhodes
Journal:  Br J Dermatol       Date:  2008-10-13       Impact factor: 9.302

5.  Comparison of topical methyl aminolevulinate photodynamic therapy with cryotherapy or Fluorouracil for treatment of squamous cell carcinoma in situ: Results of a multicenter randomized trial.

Authors:  Colin Morton; Michael Horn; Joyce Leman; Brigitte Tack; Christophe Bedane; Milan Tjioe; Sally Ibbotson; Abdallah Khemis; Peter Wolf
Journal:  Arch Dermatol       Date:  2006-06

6.  Effect of subcutaneous infiltration anesthesia on pain in photodynamic therapy: a controlled open pilot trial.

Authors:  Claudia Borelli; Thomas Herzinger; Kathrin Merk; Carola Berking; Christian Kunte; Gerd Plewig; Klaus Degitz
Journal:  Dermatol Surg       Date:  2007-03       Impact factor: 3.398

7.  Physicochemical and safety evaluation of 5-aminolevulinic acid in novel liposomes as carrier for skin delivery.

Authors:  Yi-Ping Fang; Pao-Chu Wu; Yi-Hung Tsai; Yaw-Bin Huang
Journal:  J Liposome Res       Date:  2008       Impact factor: 3.648

Review 8.  The Asian dermatologic patient: review of common pigmentary disorders and cutaneous diseases.

Authors:  Stephanie G Y Ho; Henry H L Chan
Journal:  Am J Clin Dermatol       Date:  2009       Impact factor: 7.403

9.  Enhancement of topical 5-aminolaevulinic acid delivery by erbium:YAG laser and microdermabrasion: a comparison with iontophoresis and electroporation.

Authors:  J-Y Fang; W-R Lee; S-C Shen; Y-P Fang; C-H Hu
Journal:  Br J Dermatol       Date:  2004-07       Impact factor: 9.302

10.  Methylaminolaevulinate-based photodynamic therapy of Bowen's disease and squamous cell carcinoma.

Authors:  P G Calzavara-Pinton; M Venturini; R Sala; R Capezzera; G Parrinello; C Specchia; C Zane
Journal:  Br J Dermatol       Date:  2008-07-01       Impact factor: 9.302

View more
  2 in total

Review 1.  Laser-assisted drug delivery in dermatology: from animal models to clinical practice.

Authors:  Faisal R Ali; Firas Al-Niaimi
Journal:  Lasers Med Sci       Date:  2015-12-22       Impact factor: 3.161

2.  Photodynamic therapy in Bowen disease of the first web space of the hand.

Authors:  Soo-Eun Jung; Sue Kyung Kim; You Chan Kim
Journal:  Ann Dermatol       Date:  2015-02-03       Impact factor: 1.444

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.